WebMD describes how radioactive seed implants, a form of radiation therapy called brachytherapy, is used to treat prostate cancer. Learn about the procedure, side effects, and risks.

Brachytherapy for prostate cancer. Brachytherapy is a type of internal radiotherapy. This means that you have a radioactive source inside the prostate. The radioactive source releases radiation to ...

Brachytherapy is an internal radiation therapy for treating some types of cancer. It involves placing radioactive material, usually in the form of seeds, pellets, ribbons, or wires, inside or next ...

Prostate high dose rate brachytherapy. Information for patients University Hospital Southampton NHS Foundation Trust. Last updated 2019. High dose rate prostate brachytherapy: an overview of the ...

For temporary brachytherapy, a catheter or applicator is used to deliver the radiotherapy to a target site. In cases of low dose radiotherapy, the radioactive material is usually placed in the ...

Brachytherapy works from the inside out. You may hear it called internal radiation therapy. It delivers radiation from small radioactive seeds or pellets, each the size of a grain of rice , that ...

Vaginal cuff brachytherapy is a treatment that can help prevent endometrial cancer from spreading to the upper part of your vagina. It involves inserting a radioactive cylinder into your vagina to ...

Frequently asked questions » What are the different kinds of brachytherapy treatments?» Does temporary brachytherapy treatment require hospitalization?» Does permanent brachytherapy treatment require ...

Doctors use brachytherapy, a type of radiation therapy, to treat cervical cancer. Read about the goal of brachytherapy, the procedure, and side effects.

“Brachytherapy is an important tool in our toolbox, but it is one of many options we provide within our multidisciplinary program.” For example, radiation oncology, neuro-oncology, and thoracic ...

The 15-year estimates for any SMN were 15.2% with brachytherapy and 11.6% with radical therapy, a difference that did not achieve statistical significance (HR 1.12, 95% CI 0.98-1.27, P=0.092).

“Brachytherapy gives them a longer interval of freedom from revascularization,” he said. Waksman said there is a need for more research to understand why DES fail, and the mechanisms behind that. “It ...